HAEMONETICS CORP
For the period ended Sep 26, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 26, 2026 · Filed Nov 5, 2026
HAE$118.21-1.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 1. Financial Statements
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
| Three Months Ended | Six Months Ended | |||
|---|---|---|---|---|
| September 26, 2026 | September 27, 2025 | September 26, 2026 | September 27, 2025 | |
| (Dollars and Shares in Thousands, Except Per Share Data) | ||||
| Net revenues | $357,759 | $327,315 | $697,139 | $648,709 |
| Cost of goods sold | 136,846 | 132,571 | 273,423 | 261,721 |
| Gross profit | 220,913 | 194,744 | 423,716 | 386,988 |
| Operating expenses: | ||||
| Research and development | 17,029 | 14,872 | 33,229 | 31,133 |
| Selling, general and administrative | 118,361 | 101,615 | 237,302 | 212,334 |
| Amortization of acquired intangible assets | 10,403 | 11,182 | 20,607 | 22,574 |
| Impairment of intangible assets | — | 8,584 | — | 8,584 |
| Total operating expenses | 145,793 | 136,253 | 291,138 | 274,625 |
| Operating income | 75,120 | 58,491 | 132,578 | 112,363 |
| Interest and other expense, net | (12,261) | (7,206) | (22,145) | (15,909) |
| Income before provision for income taxes | 62,859 | 51,285 | 110,433 | 96,454 |
| Provision for income taxes | 16,554 | 12,601 | 31,118 | 23,739 |
| Net income | $46,305 | $38,684 | $79,315 | $72,715 |
| Net income per common share: | ||||
| Basic | $1.02 | $0.81 | $1.75 | $1.52 |
| Diluted | $1.00 | $0.81 | $1.72 | $1.51 |
| Weighted average shares outstanding | ||||
| Basic | 45,500 | 47,590 | 45,430 | 47,850 |
| Diluted | 46,463 | 47,664 | 46,084 | 48,009 |
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
| Three Months Ended | Six Months Ended | |||
|---|---|---|---|---|
| September 26, 2026 | September 27, 2025 | September 26, 2026 | September 27, 2025 | |
| (Dollars in Thousands) | ||||
| Net income | $46,305 | $38,684 | $79,315 | $72,715 |
| Other comprehensive income (loss): | ||||
| Foreign currency translation adjustment, net of tax | 1,493 | (4,419) | (3,215) | 14,888 |
| Unrealized gain (loss) on cash flow hedges, net of tax | 1,534 | 336 | 2,332 | (184) |
| Reclassifications into earnings of cash flow hedge gains, net of tax | (115) | (206) | (220) | (151) |
| Other comprehensive income (loss) | 2,912 | (4,289) | (1,103) | 14,553 |
| Comprehensive income | $49,217 | $34,395 | $78,212 | $87,268 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.